Schedule 13G ownership disclosure

PROVECTUS BIOPHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 74373PB99

Event date: 2023-05-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
13.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-015966
Form type
SC 13G
Filer
Morris Jeffrey Allen
CIK
CIK 1959175
Filed
May 09, 2023
Reporting period
May 08, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub